Palliative care in metastatic head and neck cancer

被引：13

作者：

Civantos, Alyssa M. ^{[1
]}

Prasad, Aman ^{[1
]}

Carey, Ryan M. ^{[2
]}

Bur, Andres M. ^{[3
]}

Mady, Leila J. ^{[2
,4
]}

Brody, Robert M. ^{[2
]}

Rajasekaran, Karthik ^{[2
]}

Cannady, Steven B. ^{[2
]}

Hartner, Lee ^{[5
]}

Ibrahim, Said A. ^{[6
]}

Newman, Jason G. ^{[2
]}

Brant, Jason A. ^{[2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA

[3] Univ Kansas, Dept Otolaryngol Head & Neck Surg, Kansas City, KS USA

[4] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA

[5] Univ Penn, Dept Hematol, Med Oncol, Philadelphia, PA 19104 USA

[6] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2021年 / 43卷 / 09期

关键词：

end of life care; head and neck cancer; metastatic cancer; palliative care; socioeconomic factors; END-OF-LIFE; PATTERNS; SURVIVAL;

D O I：

10.1002/hed.26761

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

Background Due to inherent impact on quality of life, metastatic head and neck cancer patients are well-suited to benefit from palliative care (PC). Our objective was to examine factors that shape PC utilization and implications for overall survival in stage IVc head and neck cancer patients. Methods A retrospective study of patients with stage IVc head and neck cancer in the National Cancer Database from 2004 and 2015 was conducted. Results 7794 cases met inclusion criteria, of which 19.3% received PC. PC use was associated with more recent years of diagnosis, Northeast facility geography, and non-private insurances (p < 0.05). Compared to no PC, "interventional" PC, defined as palliative surgery, radiation, and/or chemotherapy, and "pain management only" PC were associated with lower overall survival (p < 0.05). Conclusions PC use increased over time and was associated with demographic and clinical factors. There remains opportunity for improvement in optimal implementation of palliative care.

引用

页码：2764 / 2777

页数：14

共 50 条

[41] The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care [J].

Kishino, Takehito ;

Mori, Terushige ;

Miyashita, Takenori ;

Ouchi, Yohei ;

Samukawa, Yasushi ;

Fukumura, Takashi ;

Takahashi, Satoshi ;

Monden, Nobuya ;

Akisada, Naoki ;

Hayashi, Yuji ;

Nakamura, Masataka ;

Hoshikawa, Hiroshi .

ENT-EAR NOSE & THROAT JOURNAL, 2023, 102 (06) :379-384

[42] Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers [J].

Lok, Benjamin H. ;

Jiang, Ginger ;

Gutiontov, Stanley ;

Lanning, Ryan M. ;

Sridhara, Sudeepta ;

Sherman, Eric J. ;

Tsai, Chiaojung Jillian ;

McBride, Sean M. ;

Riaz, Nadeem ;

Lee, Nancy Y. .

ORAL ONCOLOGY, 2015, 51 (10) :957-962

[43] Acupuncture in palliative care for management of sequelae of head and neck cancer treatment: Scoping review [J].

Dote, Samyra Yukiko Tazaki ;

do Nascimento, Camila Teixeira ;

Goiato, Marcelo Coelho ;

dos Santos, Daniela Micheline .

ADVANCES IN INTEGRATIVE MEDICINE, 2025, 12 (04)

[44] Palliative intent treatment for head and neck cancer: an analysis of practice and outcomes [J].

Begbie, F. D. ;

Douglas, C. M. ;

Finlay, F. ;

Montgomery, J. .

JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2019, 133 (04) :313-317

[45] Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy [J].

Garcia-Anaya, Maria J. ;

Ordonez, Rafael ;

Toledo, Maria D. ;

Correa, Raquel C. ;

Otero, Ana ;

Roman, Alicia ;

Garcia-Rios, Isabel ;

Medina, Jose A. ;

Gomez-Millan, Jaime .

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (03) :798-804

[46] Improving end-of-life care for head and neck cancer patients [J].

Shuman, Andrew G. ;

Fins, Joseph J. ;

Prince, Mark E. .

EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (03) :335-343

[47] End-of-Life Care among Head and Neck Cancer Patients [J].

Shuman, Andrew G. ;

Yang, Ye ;

Taylor, Jeremy M. G. ;

Prince, Mark E. .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2011, 144 (05) :733-739

[48] Impact of Facility Volume on Overall Survival in Patients With Head and Neck Cancer Undergoing Palliative Treatment [J].

Kaki, Praneet C. ;

Patel, Aman M. ;

Revercomb, Lucy ;

Maxwell, Russell ;

Brant, Jason A. ;

Brody, Robert M. ;

Cannady, Steven B. ;

Carey, Ryan M. .

AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2025, 42 (09) :899-913

[49] Initial Experience of Head and Neck Cancer Patients Treated in an Oncologist Led Palliative Cancer Care Clinic at a Tertiary Cancer Care Center in Uttar Pradesh: Is the Initiative of a Full-fledged Palliative Care for Cancer Patients Justified [J].

Lal, Punita ;

Verma, Mranalini ;

Kumar, Gaurav ;

Shrivastava, Resham ;

Kumar, Shaleen .

INDIAN JOURNAL OF PALLIATIVE CARE, 2016, 22 (04) :477-484

[50] Immunotherapy for recurrent/metastatic head and neck cancer [J].

Alfieri, Salvatore ;

Cavalieri, Stefano ;

Licitra, Lisa .

CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2018, 26 (02) :152-156

← 1 2 3 4 5 →